139 related articles for article (PubMed ID: 17889580)
21. Effects of erdosteine on cyclosporin-A-induced nephrotoxicity.
Tutanc M; Arica V; Yılmaz N; Nacar A; Zararsiz I; Basarslan F; Tutanc OD; Nacar E
Hum Exp Toxicol; 2012 Jun; 31(6):565-73. PubMed ID: 21813577
[TBL] [Abstract][Full Text] [Related]
22. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
23. Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats.
Yilmaz HR; Uz E; Gökalp O; Ozçelik N; Ciçek E; Ozer MK
Toxicol Ind Health; 2008 Sep; 24(8):519-24. PubMed ID: 19039079
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
25. A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations.
Dal Negro RW; Micheletto C; Tognella S; Visconti M; Guerriero M; Sandri MF
COPD; 2005 Mar; 2(1):7-16. PubMed ID: 17136956
[TBL] [Abstract][Full Text] [Related]
26. Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis.
Olivieri D; Del Donno M; Casalini A; D'Ippolito R; Fregnan GB
Respiration; 1991; 58(2):91-4. PubMed ID: 1862257
[TBL] [Abstract][Full Text] [Related]
27. Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokers.
Basyigit I; Yildiz F; Cekmen M; Duman C; Bulut O
Drugs R D; 2005; 6(2):83-9. PubMed ID: 15777101
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
29. The effects of erdosteine on lung injury induced by the ischemia-reperfusion of the hind-limbs in rats.
Sirmali M; Uz E; Sirmali R; Kilbaş A; Yilmaz HR; Ağaçkiran Y; Altuntaş I; Delibaş N
J Surg Res; 2008 Apr; 145(2):303-7. PubMed ID: 17574582
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of pro-inflammatory cytokines in intra-epithelial T cells between trachea and bronchi distinguishes severity of COPD.
Hodge G; Reynolds PN; Holmes M; Hodge S
Cytokine; 2012 Dec; 60(3):843-8. PubMed ID: 22929410
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress levels in exhaled breath condensate associated with COPD and smoking.
Inonu H; Doruk S; Sahin S; Erkorkmaz U; Celik D; Celikel S; Seyfikli Z
Respir Care; 2012 Mar; 57(3):413-9. PubMed ID: 21968597
[TBL] [Abstract][Full Text] [Related]
32. Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats.
Kuvandik G; Duru M; Nacar A; Yonden Z; Helvaci R; Koc A; Kozlu T; Kaya H; Sogüt S
Toxicol Pathol; 2008 Jul; 36(5):714-9. PubMed ID: 18648099
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of erdosteine against ototoxicity induced by cisplatin in rats.
Kalcioglu MT; Kizilay A; Gulec M; Karatas E; Iraz M; Akyol O; Egri M; Ozturan O
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):856-63. PubMed ID: 15742177
[TBL] [Abstract][Full Text] [Related]
34. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
35. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
36. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
[TBL] [Abstract][Full Text] [Related]
37. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
[TBL] [Abstract][Full Text] [Related]
38. The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells.
Demiralay R; Gürsan N; Erdem H
J Appl Toxicol; 2007; 27(3):247-54. PubMed ID: 17216608
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injury.
Demiralay R; Gürsan N; Ozbilim G; Erdogan G; Demirci E
J Appl Toxicol; 2006; 26(4):301-8. PubMed ID: 16489578
[TBL] [Abstract][Full Text] [Related]
40. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
